Christina Yau

机构：University of California, San Francisco, University of San Francisco · ORCID：0000-0002-1937-0859

发表论文 564 篇 · 总被引 72230 次 · h-index 89

代表论文

• Risk-Based vs Annual Breast Cancer Screening (2025 · JAMA · 被引 46)
• Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors (2025 · Nature Communications · 被引 16)
• Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial (2025 · Breast Cancer Research · 被引 11)
• Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial (2025 · Annals of Surgical Oncology · 被引 8)
• Immune Subtyping Identifies Patients With Hormone Receptor–Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial (2025 · JCO Precision Oncology · 被引 5)
• Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second events (2025 · npj Breast Cancer · 被引 4)